Mylan says Icahn doesn&#39;t understand value of King deal
107025
Mylan Laboratories Inc. continued to insist Monday that its $4 billion acquisition of King Pharmaceuticals Inc. was in the company&#39;s best interest, following a meeting last week with Carl Icahn, who opposes the deal.
748008
Icahn is involved in the Mylan-King Pharmaceuticals deal for his benefit only.
191627
Check--or checkmate? Carl Icahn, attempting to block Mylan Laboratories (nyse: MYL - news - people ) in its buyup of King Pharmaceuticals (nyse: KG - news - people ), made his move: Earlier this month, the
414677
Mylan Laboratories Inc. on Friday affirmed its commitment to buy King Pharmaceuticals Inc. and said it would issue an earnings guidance for its 2005 fiscal year as soon as it could.
402032
Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) , a maker of generic drugs, and King Pharmaceutical (KG.N: Quote, Profile, Research) on Wednesday reaffirmed their commitment
476487
The board of Mylan Laboratories rebuffed the financier Carl C. Icahn&#39;s bid to buy the company yesterday, saying it remained committed to acquiring the brand-name drug maker King Pharmaceuticals.
761363
Temple-Inland Inc. TIN.N on Friday  said Wall Street financier Carl Icahn and one of his funds  filed for clearance to buy up to $1 billion, or a little more  than a quarter, of the company's common stock.
210669
Mylan Laboratories Inc. MYL.N on  Wednesday said investor Carl Icahn's opposition to Mylan's  proposed purchase of King Pharmaceuticals Inc. KG.N does not  affect Mylan's commitment to complete the transaction.
84238
Mylan Laboratories Inc. MYL.N on  Friday said its board of directors remains committed to the  purchase of King Pharmaceuticals Inc. KG.N, despite news that  billionaire investor Carl Icahn won regulatory approval to buy  up to 11.9 percent of Mylan's shares.
260004
Mylan Laboratories Inc. on Wednesday said it was unlikely to complete its &#36;3.80 billion acquisition of King Pharmaceuticals Inc. at the current price because of King's need to restate earnings.
94977
Mylan Laboratories Inc.&#39;s board Monday shunned an overture by financier Carl Icahn and said the company intends to remain independent while pursuing its proposed acquisition of King Pharmaceuticals, which Icahn opposes.
639540
PITTSBURGH Carl Icahn, the largest shareholder of Mylan Laboratories, is now threatening to push for new company directors to stop the generic drug maker&#39;s four (B) billion-dollar takeover bid of King Pharmaceuticals.
754264
PHILADELPHIA, Aug 19  - Shares of Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) surged more than 10 percent on Thursday after billionaire investor Carl Icahn got federal regulatory approval to buy up 11.9 percent of ...
700046
Billionaire investor Carl Icahn's American Real Estate Partners LP  raised its takeover offer for Lear Corp.  to about $3 billion, but the auto parts maker's second biggest shareholder remained unconvinced.
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
102229
The Pittsburgh-based drug maker Mylan shares shot up 10 percent after Carl Ichan offered $5.38 billion for the company&#39;s shares he doesn&#39;t already own.
723851
Generic drug maker Mylan Laboratories Inc.  said on Friday it expects to raise $993.6 million, following a pricing of its public offerings of notes and shares.